- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04073277
Acupuncture Needle Modified With Supercritical Fluid
Study on Improving Acupuncture Needles and Physical Properties of Acupoints With Supercritical Fluid
Objective: To compare the differences in the needling sensation with acupuncture needles surface treated with nitrogen applied supercritical fluid (SCF-N) and stainless steel needles.
Materials and Methods: This was a double-blind prospective cohort study. The acupuncture needles were randomly used in this experiment, including the SCF-N-treated needles and the control stainless steel needles. LI 4 (Hegu) and LI 11 (Quchi) acupuncture points in the Yangming Large Intestine Meridian of Hand were treated. Physical electrical resistance , scanning electron microscopy, energy dispersive spectrometry, and visual analog scale score including the sensations of soreness, numbness, distention, and heaviness were assessed.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This was a double-blinded prospective cohort study. The acupuncture needles were first separated into two groups. One group of needles was subjected to SCF-N treatment while the other was not. The needles were then randomly analyzed with scanning electron microscope and energy dispersive X-ray spectroscopy to ensure quality and minimize experimental error. For each participant, one hand was randomly assigned to the treatment group with SCF-N-treated acupuncture needles and the other hand was assigned to the control group with the stainless steel needles. The time interval between the acupuncture treatment of the two groups was about two hours. In order to examine and distinguish the difference between the two groups, de-qi VAS score was recorded by the volunteers during needle insertion and the electrical resistance by electrical measurement.
The acupuncture needles used in this experiment, including the SCF-N-treated needles and the control stainless steel needles, were produced under the same conditions, in the same factory (Dong Bang acupuncture Inc.), and on the same day, to minimize experimental error.
The process of SCF treatment:. First, the stainless steel chamber and quartz carrier were sterilized using alcohol and autoclaving. Next, the needles were placed on the quartz carrier with the tip pointing upwards and then placed in the chamber and covered. Carbon dioxide was used to remove atmospheric components from the chamber and required volume of ammonia gas was passed. The pressure was increased up to 3000 pound per square inch(psi) and temperature up to 120℃. An hour later, the pressure was relieved and the process of SCF treatment completed. After completion of the treatment, the needles were then randomly selected for material analysis and electrical measurement. Following this, the needles were stored in a vacuum bag. This was done to reduce the influence of atmospheric contaminants on the needles after treatment, resulting in oxidation and rusting. Finally, there would be heterogeneous contact between the inorganic metal and the acupuncture needle. Hence, nitrogen was selected as the main agent for SCF treatment.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kaohsiung, Taiwan, 833
- Kaohsiung Chang Gung Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy volunteer aged 20 to 40 years
- Provided informed consent
Exclusion Criteria:
- Women with pregnancy or breast feeding
- Bleeding tendencies (platelet counts less than 20000 and/or thrombocytopenic purpura)
- Volunteers with chronic medical conditions and anti-coagulants use
- Volunteers with pacemakers
- Fasting
- Unwilling to provide informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: SCF-N-treated needle acupuncture
For each participant, one hand was randomly assigned to the experimental group with SCF-N-treated needle acupuncture .
|
The SCF-N-treated needles were used for acupuncture at LI 4 (Hegu) and LI 11 (Quchi) acupoints in the experimental groups..
|
|
Sham Comparator: untreated needle acupuncture
The other hand of participant in experimental group was assigned to the control group with untreated needle acupuncture.
|
he untreated needles were used for acupuncture at LI 4 (Hegu) and LI 11 (Quchi) acupoints in the control groups.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Resistance of the meridian
Time Frame: immediately after acupuncture needling
|
Electrical resistance was measured by applying a fixed electric current (110 µA) for 1 second and recording the I-V curve.
A linear relationship of voltage=current x resistance was expected.
The analyzer used in this experiment was Agilent B1500, a semi-conductor analyzer able to measure electrical resistance with high accuracy.
|
immediately after acupuncture needling
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Modified Visual Analog Scale (VAS) Score
Time Frame: immediately after acupuncture needling
|
The VAS score was used to assess the needling sensations of de-qi, i.e. distension, soreness, heaviness, or numbness.
VAS score 0 indicated no sensation, while VAS 10 indicated the strongest sensation.
|
immediately after acupuncture needling
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CMRPG8G0331
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Participants
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Not yet recruitingHealthy Participants | Healthy Adult ParticipantsUnited States
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
Touro University, CaliforniaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingHealthy Participants | Obese But Otherwise Healthy ParticipantsUnited States
-
Beijing Tide Pharmaceutical Co., LtdRecruitingHealthy | Healthy ParticipantsChina
-
Aston UniversityCooperVision, Inc.Enrolling by invitationHealthy | Healthy ParticipantsUnited Kingdom
-
Universidad San SebastiánAgencia Nacional de Investigación y DesarrolloNot yet recruitingHealthy | Healthy Adult ParticipantsChile
-
Standard Process Inc.Recruiting
-
PfizerCompletedHealthy Subjects | Healthy ParticipantsUnited States
-
Simcere Pharmaceutical Co., LtdNot yet recruiting
-
Fresenius KabiOxford Brookes UniversityNot yet recruiting
Clinical Trials on SCF-N-treated needles
-
Dr. F. Köhler Chemie GmbHSuspendedCongenital Heart MalformationsGermany
-
Médecins du MondeLondon School of Hygiene and Tropical Medicine; University of Bristol; PATH; UN... and other collaboratorsRecruitingHepatitis | Hiv | Drug UseArmenia, Georgia, Tanzania
-
Baylor College of MedicineCompletedHIV Infection | Erythrocyte Glutathione DeficiencyUnited States
-
University of UlmCompletedCOVID-19 | Critically Ill | Outcome, Fatal | Interleukin 6 | TocilizumabGermany
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Assiut UniversityNot yet recruiting
-
Chipscreen Biosciences, Ltd.CompletedDiffuse Large B-cell LymphomaChina
-
Fred Hutchinson Cancer CenterTerminatedGlioblastoma | GliosarcomaUnited States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedMucinous Adenocarcinoma of the Rectum | Signet Ring Adenocarcinoma of the Rectum | Stage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Rectal Adenocarcinoma | Recurrent Rectal CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Rectal Carcinoma | Stage IIIA Rectal Cancer AJCC v7 | Stage IIIB Rectal Cancer AJCC v7 | Stage IIIC Rectal Cancer AJCC v7 | Stage IVA Rectal Cancer AJCC v7 | Stage IVB Rectal Cancer AJCC v7 | Rectal Mucinous Adenocarcinoma | Rectal Signet Ring Cell Adenocarcinoma | Stage IIA Rectal Cancer... and other conditionsUnited States